Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Owens

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
The American Journal of Managed Care|September 8, 2000
Choosing the ideal antibiotic therapy and the role of the newer fluoroquinolones in respiratory tract infectionsR C Owens
Pharmacotherapy|March 20, 2001
Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointesR C Owens
Your Oklahoma Dental Association Journal|July 1, 1974
"The relay": the president's messageR C Owens
Connecticut Medicine|November 1, 1996
Oral ganciclovir: role in maintenance therapy for CMV retinitis in AIDS patientsR C Owens, J W Ross
The Medical Clinics of North America|January 13, 2001
Clinical use of the fluoroquinolonesR C Owens, P G Ambrose
Seminars in Respiratory and Critical Care Medicine|August 10, 2005
New antibiotics in pulmonary and critical care medicine: focus on advanced generation quinolones and cephalosporinsP G Ambrose, R C Owens
The Medical Clinics of North America|January 13, 2001
Antimicrobial pharmacodynamicsP G Ambrose, R C Owens, D Grasela
Connecticut Medicine|April 1, 1997
Ceftazidime to cefepime formulary switch: pharmacodynamic and pharmacoeconomic rationaleR C Owens, P G Ambrose, R Quintiliani
Pharmacotherapy|July 1, 1997
Ceftibuten: an overviewR C Owens, C H Nightingale, D P Nicolau
European Journal of Cancer Care|September 27, 2014
What is a new drug worth? An innovative model for performance-based pricingG Dranitsaris, K Dorward, R C Owens, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
The American Journal of Managed Care|September 8, 2000
Choosing the ideal antibiotic therapy and the role of the newer fluoroquinolones in respiratory tract infectionsR C Owens
Pharmacotherapy|March 20, 2001
Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointesR C Owens
Your Oklahoma Dental Association Journal|July 1, 1974
"The relay": the president's messageR C Owens
Connecticut Medicine|November 1, 1996
Oral ganciclovir: role in maintenance therapy for CMV retinitis in AIDS patientsR C Owens, J W Ross
The Medical Clinics of North America|January 13, 2001
Clinical use of the fluoroquinolonesR C Owens, P G Ambrose
Seminars in Respiratory and Critical Care Medicine|August 10, 2005
New antibiotics in pulmonary and critical care medicine: focus on advanced generation quinolones and cephalosporinsP G Ambrose, R C Owens
The Medical Clinics of North America|January 13, 2001
Antimicrobial pharmacodynamicsP G Ambrose, R C Owens, D Grasela
Connecticut Medicine|April 1, 1997
Ceftazidime to cefepime formulary switch: pharmacodynamic and pharmacoeconomic rationaleR C Owens, P G Ambrose, R Quintiliani
Pharmacotherapy|July 1, 1997
Ceftibuten: an overviewR C Owens, C H Nightingale, D P Nicolau
European Journal of Cancer Care|September 27, 2014
What is a new drug worth? An innovative model for performance-based pricingG Dranitsaris, K Dorward, R C Owens, et al.
Pageof 3